Interleukin-17 Contributes to Chikungunya Virus-Induced Disease-Reference-Cited by-同舟云学术

Interleukin-17 Contributes to Chikungunya Virus-Induced Disease

Published:2022-04-26 Issue:2 Volume:13 Page:
ISSN:2150-7511
Container-title:mBio
language:en
Short-container-title:mBio

Author:

Liu Xiang¹²³^ORCID,Poo Yee-Suan¹²³,Alves Juliana C.⁴,Almeida Roque P.⁴,Mostafavi Helen¹²³,Tang Patrick Chun Hean¹²³,Bucala Richard⁵,Teixeira Mauro M.⁶,Taylor Adam¹²³^ORCID,Zaid Ali¹²³^ORCID,Mahalingam Suresh¹²³^ORCID

Affiliation:

1. Menzies Health Institute Queensland, Griffith University, Southport, Queensland, Australia

2. School of Medical Sciences, Griffith University, Southport, Queensland, Australia

3. Global Virus Network Centre of Excellence in Arboviruses, Griffith University, Southport, Queensland, Australia

4. Division of Immunology and Molecular Biology Laboratory, University Hospital/EBSERH, Federal University of Sergipe, Aracaju, Sergipe, Brazil

5. Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA

6. Department of Biochemistry and Immunology, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

Abstract

CHIKV has been prevalent in Africa, Asia, and the Indian Ocean Islands for decades. There are currently no clinically approved vaccines or specific antiviral drugs targeting CHIKV.

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Department of Health | National Health and Medical Research Council

MCTI | Financiadora de Estudos e Projetos

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mbio.00289-22

Reference25 articles.

1. Rheumatic manifestations of chikungunya: emerging concepts and interventions